Bright Minds Biosciences DRUG
NASDAQ DRUG
$22.96 -0.49 (-2.09%)
As of: Nov 12, 2026 · 10:37 AM EST

Bright Minds Biosciences (DRUG) Return on Assets [ROA] (2023 - 2026)

Updated

Bright Minds Biosciences' Return on Assets [ROA] was 1.83% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 8.81 percentage points from 10.64% a year earlier and down 4.76 percentage points from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Return on Assets [ROA] (2023 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Return on Assets [ROA] at Bright Minds Biosciences came in at -26.97%, up 15.99 percentage points from FY2024.

  • Return on Assets [ROA] has now increased for three consecutive fiscal years, with a five-year change of +72.72 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Assets [ROA] was -42.96% in FY2024 (+32.10 pp), -75.06% in FY2023 (+92576702.23 pp), -92576777.28% in FY2022 (-9667453.88 pp) and -82909323.41% in FY2021 (-82909223.71 pp).
  • Quarterly Return on Assets [ROA] has moved between -167681982.23% (fiscal Q3 2023) and 10.64% (fiscal Q3 2025) over five years.
  • Compared with a year earlier, Return on Assets [ROA] was higher in five of the last eight quarters, with an average year-over-year change of +56.36 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was fiscal Q3 2024 (a gain of 167681852.06 percentage points); the worst was fiscal Q3 2026 (a drop of 8.81 percentage points).
  • Per Business Quant data, DRUG's Return on Assets [ROA] in the three fiscal quarters before Q3 2026 was 6.59% (Q2 2026), -13.86% (Q1 2026) and -5.49% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Bright Minds Biosciences 172.65 Mn -390.95 Mn - -8.29%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.29%
Mar 31, 2026 -14.03%
Dec 31, 2025 -23.33%
Sep 30, 2025 -17.72%
Jun 30, 2025 -16.38%
Mar 31, 2025 -6.04%
Dec 31, 2024 -3.51%
Sep 30, 2024 -45.31%
Jun 30, 2024 -56.02%
Mar 31, 2024 -77.53%
Dec 31, 2023 -96.64%
Sep 30, 2023 -95.13%
Jun 30, 2023 -95.75%
Mar 31, 2023 -95.46%
API Access

Bright Minds Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEY